Event Participants
Executives
Not disclosed in the provided materials
Investor presentation contacts referenced: Rajeev Kumar, Natarajan Ramamurthy
Analysts
Not available
Transcript incomplete - live Q&A participant list not available for summary.
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Consolidated Total Income | ₹3,328 million | +11% YoY (vs ₹3,006 million in Q1FY26); +9% QoQ (vs ₹3,063 million in Q4FY26); growth led by improving product mix |
| Standalone Total Income | ₹3,321 million | +14% YoY (vs ₹2,915 million); +9% QoQ (vs ₹3,047 million) |
| Industrial Salt Revenue | ₹1,713 million | -12% YoY; volumes 0.98 million tons (9,82,080 tons vs 11,16,197 tons in Q1FY26); shipments impacted by logistics and cost pressures |
| Bromine Revenue | ₹1,333 million | +58% YoY (vs ₹844 million); volumes 4,175 tons (vs 3,968 tons YoY / 3,731 tons QoQ); supported by firmer realisations and improving throughput |
| Bromine Derivatives (Acume) Revenue | ₹296 million | +28% YoY (vs ₹232 million); led by organic bromides; volumes 1,470 tons (vs 1,714 tons YoY) |
| SOP Revenue | ₹113 million | Scaled during the quarter; management expects to maintain business momentum |
| Idealis Mudchemie Revenue | ₹4 million | Early-stage contribution; focus remains on operationalizing plants and ongoing certifications |
| Consolidated EBITDA | ₹729 million | -16% YoY (vs ₹863 million); +49% QoQ (vs ₹491 million); margin compressed amid higher logistics and other expenses |
| Standalone EBITDA | ₹839 million | -12% YoY (vs ₹958 million); +26% QoQ (vs ₹664 million) |
| Acume EBITDA | ₹19 million | Turned EBITDA-positive vs ₹-27 million in Q1FY26 on improved capacity utilization |
| Idealis EBITDA | ₹-13 million | Wider loss vs ₹-6 million in Q1FY26 as plants are being operationalized |
| Neun EBITDA | ₹-6 million | Early-stage losses at semiconductor step-down subsidiary |
| Consolidated EBIT | ₹497 million | -22% YoY (vs ₹634 million); +89% QoQ (vs ₹263 million) |
| Consolidated Finance Cost | ₹55 million | Flat YoY (vs ₹54 million); lower QoQ (vs ₹104 million) |
| Standalone Finance Cost | ₹86 million | +91% YoY (vs ₹45 million); elevated vs prior year |
| Consolidated PBT | ₹442 million | -24% YoY (vs ₹580 million); +178% QoQ (vs ₹159 million) |
| Consolidated PAT | ₹304 million | -24% YoY (vs ₹401 million); +149% QoQ (vs ₹122 million) |
| Standalone PAT | ₹405 million | -22% YoY (vs ₹518 million); +36% QoQ (vs ₹298 million) |
| Consolidated EPS (Basic) | ₹2.48 | vs ₹3.25 in Q1FY26 and ₹1.13 in Q4FY26 |
| Standalone EPS (Basic) | ₹3.28 | vs ₹4.20 in Q1FY26 and ₹2.41 in Q4FY26 |
| Export Mix | ~Two-thirds of operating revenue | Exports impacted by West Asia conflict via higher transit time and elevated freight costs; FY26 mix was ~78% export / 22% domestic |
Geographic & Segment Commentary
Industrial Salt: Revenue declined 12% YoY to ₹1,713 million on volumes of 0.98 million tons, with shipments hit by logistics and transportation challenges. Business remains 100% export-oriented with capacity of 7.5 million MTPA and long-term contract visibility, but near-term performance was constrained by route disruptions and freight inflation.
Bromine: Revenue rose 58% YoY to ₹1,333 million on volumes of 4,175 tons, aided by firmer realisations and steadily improving throughput. Segment retains leadership in elemental bromine merchant sales (merchant capacity 28,500 MTPA; captive 14,000 MTPA), with demand from pharma, agrochemicals, flame retardants, water treatment, oil & gas and energy storage.
Bromine Derivatives (Acume Chemicals): Revenue grew 28% YoY to ₹296 million, led by organic bromides, and EBITDA turned positive at ₹19 million (vs ₹-27 million). Plant ran at an average utilisation of ~30-35% through FY26; new compounds including PBR3, CBR, CaBR and NPBr and new customers have been added, with additional products under campaign-basis development.
SOP (Sulphate of Potash): Revenue scaled to ₹113 million in Q1FY27. Company is the only manufacturer of natural sea brine-based SOP in India (capacity 1,32,000 MTPA) and is re-engineering product/process after prior years of lower output due to higher NaCl content in KTMS; meaningful contribution expected in H2FY27.
Idealis Mudchemie (formerly Oren Hydrocarbon): Revenue contribution was ₹4 million with EBITDA loss of ₹13 million. Three plants have been commissioned across Gujarat, Andhra Pradesh and Tamil Nadu; customer trials are progressing and some orders received, while certifications and regulatory approvals remain ongoing after refurbishment delays.
Exports / Logistics Geography: Nearly two-thirds of Q1 operating revenue came from exports, with elevated transit times and freight from the West Asia conflict. Domestic logistics were further disrupted by Gujarat road-repair rerouting (distance up 50-100%) and higher fuel costs.
Company-Specific & Strategic Commentary
Zinc-Bromide Energy Storage (Offgrid Energy Labs): Offgrid inaugurated its first ZincGel® (zinc bromide) pilot manufacturing facility with an initial 10 MWh demonstration line at Hook, Hampshire, UK, moving from lab innovation to commercial pilot-scale production. ACIL holds/is acquiring ~21% on a fully diluted basis (investment ~$12 million), with direct bromine chemistry synergy and intent for a future India gigafactory.
SiC Semiconductor Fab (SiCSem): SiCSem executed the Fiscal Support Agreement with India Semiconductor Mission on May 11, 2026, marking a key milestone under Semicon India. Project is positioned as India’s first ISM-approved commercial compound semiconductor fab and ATMP facility at Info Valley, Bhubaneswar, Odisha, targeting 60,000 wafers and packaging capacity of 96 million units annually for EVs, renewables, data centers, fast chargers, industrial power electronics and railways.
Clas-SiC Technology Access: ACIL holds ~21.33–21.84% in Clas-SiC Wafer Fab Limited, UK (primary subscription GBP 10 million; secondary GBP 5 million), securing exclusive access to SiC technology for the Indian market and supporting SiCSem’s MOSFET/diode roadmap.
Bromine Downstream Expansion: Clear brine fluids and PTA catalyst capacities have commenced; flame retardant bromine (10,000 MTPA, under evaluation) is expected to come on stream over the next 12-18 months, with stated synergies into semiconductor and battery businesses.
Logistics Mitigation: Own-fleet trips were impacted by ~10% despite longer routes; company is working with third-party logistics, has started shipments from Kandla, and is expanding the in-house truck fleet for better control.
Group Structure / Portfolio: Diversification spans marine chemicals → bromine derivatives → specialty mud chemicals → SiC power devices → energy storage, with nine manufacturing plants and FY26 consolidated revenue ~₹1,108 crores, EBITDA ~₹266 crores, PAT ~₹105 crores.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| SOP contribution | Meaningful business contribution expected in H2FY27 | Driven by re-engineered product/process and capability to manufacture & sell Schoenite; Q1 already at ₹113 million with momentum to be maintained |
| Bromine Derivatives (Acume) | Focus on plant stabilisation and breakeven in FY27 | Utilisation averaged 30-35% through FY26; Q1 already EBITDA-positive at ₹19 million on better utilisation |
| Flame Retardant Bromine | Expected on stream over next 12-18 months | 10,000 MTPA project under evaluation; intended to extend bromine value chain |
| Idealis Mudchemie | Continue operationalizing plants; certifications ongoing | Three plants commissioned; commercialization delayed earlier by refurbishment and regulatory approvals; trials progressing with some orders received |
| Zinc bromide batteries | Pilot-scale production underway; intended India gigafactory in near future | UK 10 MWh demo line inaugurated; foundation for large-scale manufacturing tied to bromine feedstock synergy |
| SiCSem semiconductor facility | Implementation progressing post FSA with ISM (May 11, 2026) | Groundbreaking done Nov 2025; annual capacity target 60,000 wafers and 96 million packaged units; IIT Bhubaneswar developmental lab (₹65 crore) planned within facility |
Risks & Constraints
| Risk | Context |
|---|---|
| Logistics cost inflation and route disruption | Gujarat government road-repair circular increased trucking distance by 50-100% with frequent reroutes (A-D now A-B-C-D). Fuel prices rose during peak season with ~50% effective impact on per-litre fuel cost, pressuring Industrial Salt shipments and overall other expenses. |
| West Asia conflict / export freight | Exports (~two-thirds of Q1 operating revenue) faced higher transit times and elevated freight costs, affecting shipment schedules and landed economics. |
| Subsidiary losses and gestation | Acume PBT remained negative at ₹-59 million despite EBITDA turnaround; Idealis PBT ₹-40 million and Neun PBT ₹-10 million. Consolidated profitability trails standalone as new verticals ramp. |
| Industrial Salt volume softness | Volumes fell to 9.82 lakh tons from 11.16 lakh tons YoY and revenue declined 12%, making near-term mix and margin recovery dependent on logistics normalisation. |
| Execution risk on new frontiers | SiC fab, flame retardant bromine, Idealis certifications and Offgrid scale-up are multi-year, capital- and approval-intensive initiatives; presentation notes forward-looking statements are subject to cost overruns, policy and competitive risks. |
Q&A Highlights
Transcript incomplete - Q&A section not available for summary.
The provided document is the Q1FY27 investor presentation and exchange intimation dated August 01, 2026; no analyst Q&A transcript was included.
Key Takeaway
Archean Chemical Industries reported Q1FY27 consolidated total income of ₹3,328 million (+11% YoY), with growth driven by bromine (+58% YoY to ₹1,333 million) and bromine derivatives (+28% YoY to ₹296 million), while industrial salt declined 12% to ₹1,713 million on logistics-constrained volumes of 0.98 million tons. Consolidated EBITDA fell to ₹729 million (-16% YoY) and PAT to ₹304 million (-24% YoY) as freight, route diversion and subsidiary gestation weighed on margins, though Acume turned EBITDA-positive at ₹19 million and SOP scaled to ₹113 million. Strategically, the company advanced dual “new frontier” bets: Offgrid’s UK zinc-bromide pilot line (10 MWh) and SiCSem’s ISM Fiscal Support Agreement for India’s first commercial compound semiconductor fab/ATMP unit. Management expects SOP to contribute meaningfully in H2FY27, Acume stabilisation/breakeven in FY27, and flame retardant bromine over 12-18 months, while near-term watch points remain logistics cost normalisation, export freight from West Asia disruption, and the path to profitability at Idealis and Neun.